Summary
Global X - Genomics & Biotechnology ETF is an ETF - a fund traded on an exchange like a stock - run by Global X. Positions inside: 52. The ten largest make up 56% of the fund.
- Yearly costs
- 0.50%
- Fund size
- $107.3M
- Positions
- 52
- Dividend yield
- 0.99%
- Running since
- 2019
What speaks for it
Nothing stands out in its favour.
What to watch
- The ten largest positions make up 56% of the fund, so its result rests on a few names.
- 100% of the fund is in one sector (Healthcare).
- 85% of the fund is in one country (United States).
- Costs of 0.50% a year are above the middle of comparable funds (0.44%).
- In the last five years its price once dropped by 75% from its high.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -1.2%
- 3 months
- +22%
- This year
- +44%
- 1 year
- +47%
- 3 years
- +79%
- 5 years
- -24%
- Avg. market cap
- $53.3B
- P/E
- -
- Forward P/E
- -
- P/S
- 7.7x
- P/B
- 4.4x
- P/FCF
- 35.8x
- EV/EBITDA
- -
- Dividend yield
- 0.14%
- ROIC
- -11.3%
- ROE
- -10.9%
- Gross margin
- 9.6%
- Operating margin
- -160.6%
- Net margin
- -147.3%
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.60
Weighted average of the 49 largest companies, which make up 99% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 MRModerna MRNA 11%
- 2 TWTwist Bioscience TWST 6.7%
- 3 TX10x Genomics, Inc. TXG 6.4%
- 4 ILIllumina ILMN 6.1%
- 5 NTNatera NTRA 5.5%
- 6 GHGuardant Health GH 5.2%
- 7 15Genscript Biotech Corporation 1548.HK 4.6%
- 8 TEBio-Techne TECH 3.6%
- 9 VRVertex Pharmaceuticals VRTX 3.3%
- 10 QGQiagen QGEN 3.3%
Positions in the fund: 52. The ten largest make up 56% of it.
Composition as of Oct 13, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 100%
- Technology 0.3%
By country
- United States 85%
- Hong Kong SAR China 4.6%
- Netherlands 4.2%
- Switzerland 2.6%
- Other countries 3.7%
By company size
- Mega cap 1.9%
- Large cap 45%
- Mid cap 41%
- Small cap 11%
- Micro cap 0.6%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (100%). Largest country: United States (85%). Largest size group: Large cap (45%).
What does it cost me?
Expensive- A year from $10,000
- $50.00
- Over 20 years
- $2,416
From every $10,000 invested the fund takes $50.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,416.
How has it done?
Losing value- A year on average, 5 years
- -5.4%
- Deepest drop
- -75%
- Yearly volatility
- 33%
Average yearly decline over the last five years: 5.4%. Deepest drop in these years: 75% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.99%
- Payments a year
- 2
- Last payment
- $0.06
Over the last 12 months it paid $0.65 per share, which is 0.99% of today's price. The last payment was $0.06 on Jun 29, 2026.
Is it easy to buy and sell?
Yes- Traded a day
- $2.29M
- Shares a day
- 35K
On an average day about $2.29M of the fund changes hands.
How expensive are the companies inside?
Rather expensive- Average Bulios Score
- 43 out of 100
Weight by Bulios Fair Price
- Undervalued 9.2%
- Fairly valued 0.0%
- Overvalued 91%
By Fair Price, 91% of the rated weight comes out as overvalued.
Counted from its largest companies (49), which make up 99% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
GN GNMX Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF | United States | 0.35% | $1.95M | - | - | 48% |
AR ARKG ARK Genomic Revolution ETF | United States | 0.75% | $1.63B | +41% | Reinvests | 42% |
WD WDNA WisdomTree BioRevolution Fund | United States | 0.45% | $2.89M | +26% | Pays out | 41% |
HL HLTH Tema Healthcare AI ETF | United States | 0.75% | $1.08M | - | - | 34% |
PB PBE Invesco Biotechnology & Genome ETF | United States | 0.59% | $292.3M | +32% | Pays out | 32% |
HE HELX Franklin Genomic Advancements ETF | United States | 0.50% | $32.9M | +22% | Pays out | 29% |
